Market Research Blog

The digital pathology market has witnessed notable changes in terms of product innovation. One of the major reasons behind this is the scope of cloud integration with pathology outcomes in laboratory operations. According to a recent report by Future Market Insights, the global digital pathology market was valued at USD 6.19 Bn in 2021 and is expected to witness a CAGR of 13.5% during the forecast period (2021 – 2031).

According to the recent research by Future Market Insights, the functional electrical stimulation market is set to witness 8.6% growth during the forecast period from 2021 to 2031. The rising incidences of injury to the central nervous system lead to enhance functional electrical stimulation market during the forecast period from 2021 to 2031. Therefore, there will be significant growth seen in the functional electrical stimulation market.

What is Driving the Demand for Functional Electrical stimulation?

The functional electrical stimulation market is driven by various factors such as rising musculoskeletal disorders, advancement in the technological field such as medical science, the rising importance of pain management therapies in different fields of medicines, and the increasing number of physiotherapists for the disorders of muscle stimulators helps decrease pain, decrease discomfort, restore muscle tone, and rehabilitate various parts of the body.

Ask for brochure of Market @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-14217

Also, the unhealthy diet and lack of physical activities and exercise tend to drive the demand for functional electrical stimulation soon.

Rising Prevalence of Musculoskeletal Disorders Likely to Propel the Growth of Functional electrical stimulation Market

The prevalence of musculoskeletal disorders is rising globally due to unhealthy diet and lack of physical activity which leads to obesity and musculoskeletal disorders.

According to WHO data of February 2021, a total of 1.71 billion people were suffering from musculoskeletal conditions worldwide. Among which low back pain causes the highest burden with a prevalence of 568 million people suffering from the condition globally.

Thus, the demand for functional electrical stimulation will increase significantly with the increasing prevalence of musculoskeletal disorders shortly.

U.S. and Canada Functional Electrical Stimulation Market Outlook

Obesity is related to nervous system disorders and can lead to the condition of stroke also where the blood stops flowing to the brain. In America, the prevalence of obesity is rising due to changing lifestyles such as having unhealthy diet choices and changing sleep schedules.

For instance, according to CDC, the prevalence of obesity increases from 30.5% to 42.4% from 2000 to 2018.

Therefore, the demand for functional electrical stimulation will increase during the forecast period from 2021 to 2031.

Europe Demand Outlook for Functional Electrical Stimulation

The prevalence of the musculoskeletal disorder is high in the region that has a direct positive impact on the electrical stimulation market. For instance, Poland and Hungary are the two European countries with the highest prevalence of musculoskeletal disorder with 6,737 and 6,697 per 100,000 population respectively.

Thus, with the rising musculoskeletal disorder, the demand for functional electrical stimulation also rises in the region.

Who are the Key Manufacturers and Suppliers of Functional Electrical Stimulation?

The key players of functional electrical stimulation include HASOMED GmbH, Bioness Inc., Trulife, Otto Bock, Odstock Medical Limited, Hobbs Rehabilitation, MotoMed, and others.

The above companies follow certain strategies like merger & acquisition, getting FDA approval, and new product launches to be at the top position in the market. For instance, in May 2017, Ottobock collaborated with Bioness for the distribution of the new FES generation from Bioness.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Integrated Functional Electrical Stimulation Market Report Highlights:

• Detailed overview of the parent market
• Changing market dynamics in the industry
• In-depth market segmentation
• Historical, current and projected market size in terms of volume and value
• Recent industry trends and developments
• Competitive landscape
• Strategies of key players and products offered
• Potential and niche segments, geographical regions exhibiting promising growth
• A neutral perspective on market performance
• Must-have information for market players to sustain and enhance their market footprint.

Note: Although care has been taken to maintain the highest levels of accuracy in FMI’s reports, recent market/vendor-specific changes may time to reflect in the analysis.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-14217

Key Segments

By Product Type:

• Wired Devices
• Wireless Devices

By Indication:

• Neurological Disorders
• Pain Management
• Musculoskeletal Disorders
• Others

By End User:

• Hospitals
• Ambulatory Surgical Centers
• Clinics

By Region:

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• Middle East and Africa

 

According to latest research by FMI, gel implants will experience substantial growth with CAGR 3.1% during the forecast period 2021-2031. Increased demand for gel implants is expected to encounter due to the rising demand of cosmetology. Increasing awareness of cosmetology procedures is expected to present lucrative opportunities to the key players of this demand outlook in the near future.

The main factors driving the growth of the gel implants market include the increased focus on physical appearance and the increasing availability of inexpensive silicone cohesive breast implants. In addition, the increasing prevalence of breast cancer and the availability of a wide range of breast implants are driving the growth of the market.

For instance, according to the America Society of Plastic Surgeons, it was estimated that approximately 1,93,073 breast augmentation surgeries were performed in 2020.

Silicone gel implants were highly preferred by all the women seeking breast augmentation surgeries since they have higher quality in terms of appearance and firmness as compared to saline ones. Thus, the increased preference of the target population is expected to increase the demand during the forecast period.

Breast augmentations are becoming increasingly popular in emerging markets. The main reasons for this are increased economic prosperity and disposable income amongst the working population, increased influence of the cosmetic and fashion industry, increased people’s awareness of the latest products and processes, and low business start-up costs.

Ask for brochure of Market @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-14220

The growing prevalence of breast cancer is another key driver that is anticipated to propel the growth of the gel implants market. According to WHO, in the year 2020, the number of diagnosed cases of breast cancer were a staggering 2.3 million, and around 685,000 deaths occurred due to breast cancer, globally.

The increasing prevalence of breast cancer has led to an increase in the number of women undergoing breast mastectomy, that is, breast augmentation. Surgical removal of one or both breasts, leading to more women undergoing breast augmentation. According to the American Society of Plastic Surgeons, approximately 36,367 women underwent breast augmentation surgeries as a preventative measure against breast cancer. Increased awareness amongst women about preventative procedures against cancer is another key driver of the gel implants market.

Prayasta: Using 3D Technology for Breast Augmentation

Bengaluru based start-up ‘Prayasta’ is reaching new heights in the breast augmentation industry. The company was established in 2017 and is developing a 3D printing technology to manufacture personalized breast implants for the target audience.

They have developed an in-house printer Silimax P250, from scratch to cater to the women who have to undergo mastectomy either due to suffering from breast cancer or as a preventative measure. The company wants to ensure the “one-to-one personalization” for all the women since every women’s body is different in structure, size, and shape so that they can provide the implant which is closest to its natural counterpart.

U.S. and Canada Gel Implants Demand Outlook

U.S. and Canada regions hold a large chunk of the gel implants market. The reason for such a high market share is due to the increased awareness of breast cancer, which is leading to many women opting for preventive mastectomy procedures.

Increased popularity and adoption of gel implants due to the higher efficacy of cohesive gel implants is expected to fuel the growth of this demand in the forecast period in this region.

For instance, on October 20, 2021, Sientra, Inc. announced that they have collaborated with a nonprofit organization ‘Mission Plasticos’ dedicating their venture to provide reconstructive surgical care to medically underserved and needy communities around the world with their program “ Reshaping Lives: Full Circle”.

Europe Gel Implants Demand Outlook

Europe holds a moderately high share in the global gel implants market. Factors such as the rising occurrence of breast cancer in Europe and the rise in breast cosmetic operations are likely to boost the market’s growth.

On the other hand, due to the disadvantages of breast implants, such as scarring or rippling, the market is anticipated to suffer a negative impact. In Europe, breast augmentation is the most popular cosmetic operation.

For instance, in April 2019, The German Federal Cabinet announced the initiation of a digital implant register for all the German patients to ensure the safety of all the patients undergoing implant surgeries.

Who are the Key Manufacturers of Gel Implants?

The key manufacturers of gel implants are

• Allergan Inc.
• Arion Laboratories
• Cereplas
• Establishment Labs
• Mentor Woldwide LLC (Johnson & Johnson Services Inc.)
• GC Aesthetics PLC
• Sientra Inc.
• Groupe Sebbin SAS
• Polytech Health & Aesthetics GmbH
• HansBiomed Co Ltd.
• Guangzhou Wanhe Plastic Materials
• Ideal Implant
• and Silimed.

On October 14, 2021, GC Aesthetics announced a new partnership with RepCa Medical, a Guatemalan distributor in Latin America. The partnership is aimed to provide their customers with the latest technology, quality, safety, innovation and support.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Gel Implants Market Report Highlights:

• Detailed overview of parent market
• Changing market dynamics in the industry
• In-depth market segmentation
• Historical, current and projected market size in terms of volume and value
• Recent industry trends and developments
• Competitive landscape
• Strategies of key players and products offered
• Potential and niche segments, geographical regions exhibiting promising growth.

Note: Although care has been taken to maintain the highest levels of accuracy in FMI’s reports, recent market/vendor-specific changes may time to reflect in the analysis

For Complete TOC @ https://www.futuremarketinsights.com/toc/rep-gb-14220

Key Segments:

By Type:

• Cohesive Gel Implants
• Highly Cohesive Gel Implants
• Gummy Bear Gel Implants

By Shape:

• Round
• Anatomical
• Tear drop

By Indication:

• Cosmetic Surgery
• Reconstruction Surgery
• Preventive Surgery

By End-User:

• Hospitals
• Cosmetology Clinics
• Ambulatory Surgical Centers

By Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• MEA

 

Various alternative therapies and treatments for fractures, which include synthetic bone grafts, amputation, and allografts, as well as non-invasive therapies, such as electrical bone growth stimulation and low-intensity ultrasound stimulations, have been introduced, which are responsible for driving the global bone growth stimulators market. According to the latest research by FMI, the global bone growth stimulators market is expected to account for US$ 1,387.7 Mn by the end of 2029. The bone growth stimulators market is estimated to grow at a CAGR of 5.2% through the forecast period 2019-2029. However, factors such as the high prices of devices and product recalls are expected to hamper the growth of the bone growth stimulators market.

Osteoporosis and osteoarthritis are among the common disabling joint disorders that are affecting millions of elderly people across the world. Some of the most common sites of osteoporotic fractures are the spine, wrists, hips, and shoulders. Thus, the increasing population suffering from orthopaedic disease is creating high demand for bone growth stimulators. The cause of delayed bone healing and fractures is not known, however, it is creating a large economic impact on the market of bone growth stimulators.

According to the latest research by Future Market Insights, the Pulmonology Lasers Market will witness growth during 2021-2031. Any type of cancer is rapidly mutating and presenting a challenge for the researchers to keep up with these mutations and develop effective treatments for them.

Lung cancer being one of the concerning risers. Prevalence of this cancer is increasing day-by-day as per the European Union and the Cancer.org. This will directly affect research and development into lung cancer in finding ways to effectively treat it and hence boosting the market growth with a CAGR of around 12.4%.

What is Driving Demand for Pulmonology Lasers Market?

Pulmonary Lasers use thermal – ablation technique where cutting and coagulation properties is used to treat complication related to the airway tract. It can act as a palliative as well as curative therapy which relieves the obstructions in the airway caused due to various complications like neoplasms, tumours, lesions, etc.

Request for Report brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-14221

Most crucial driver of the market is that this laser therapy provides curative effect for lung cancer (early stage) as well as palliative care of central airway obstruction due to a number of malignancies.

Another associated factor is that the growing number of cancer prevalence is making researchers to find treatments competent enough to keep up with this mutating disease.

The ever changing epidemiology of cancer as a disease will definitely boost professionals to keep innovating in order to make detection as early as possible; and possibly boosting this market.

Needle-based Confocal Laser Endomicroscopy (nCLE) – A lung Cancer Detection Tool

It is very challenging to successfully diagnose peripheral lung cancer with traditional bronchoscope because some target lesions can be missed out. So, a BMJ Journal article explored the feasibility of a new microscopic laser needle in order to accurately detect the lesions present in the airway.

This new technique helps in visualising the site in real time to detect these lesions. This 2021 study concluded that, this imaging and laser combo is feasible, safe and allows real-time lung cancer lesion detection. Accurate distinguishing of airway parenchyma from lung cancer lesions was seen with the help of this guidance tool.

U.S. and Canada Pulmonology Lasers Market

As per Cancer.org, 235,760 new lung cancer cases and 131,880 deaths due to lung cancer are estimated in 2021 in the US. These statistics are definitely an ally to the market growth of pulmonology lasers in the country and will drive the market towards a positive side.

Authorities here are now focusing more on investments in R&D to improve the management and treatment of these lung cancer. This collectively makes US a front runner in the pulmonology lasers market in North America region.

Europe Pulmonology Lasers Market

According to data published by European Union, 312,000 European people get affected from lung cancer every year. Owing to this, demand for advanced and swift treatment along with early detection for lung cancer is increasing. Furthermore, the rising technological advancement and increasing investment in R&D is expected to drive the market growth during the forecast period.

Who are the Key Manufacturing and Supplying Companies in Pulmonology Lasers Market?

Key players:

• Quanta System
• Hyper Photonics
• Richard Wolf
• Lumenis
• Cook Medical
• Edap Tms
• Olympus Corporation
• EMS
• Cooltouch
• Convergent Laser Technologies
• AMS
• Jena Surgical
• Solar Laser Systems
• Potent Medical
• Candela Medical

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Pulmonology Lasers Market Report Highlights:

• Detailed overview of the parent market
• Changing market dynamics in the industry
• In-depth market segmentation
• Historical, current and projected market size in terms of volume and value
• Recent industry trends and developments
• Competitive landscape
• Strategies of key players and products offered
• Potential and niche segments, geographical regions exhibiting promising growth
• A neutral perspective on market performance
• Must-have information for market players to sustain and enhance their market footprint.

Note: Although care has been taken to maintain the highest levels of accuracy in FMI’s reports, recent market/vendor-specific changes may time to reflect in the analysis.

For Complete TOC @ https://www.futuremarketinsights.com/toc/rep-gb-14221

Key Segments

By Laser Type:

• Neodymium-doped Yttrium Aluminium Garnet (Nd-YAG)
• Photodynamic

By Indication:

• Bronchogenic Carcinoma
• Malignant Lesions
• Benign Tumours
• Neoplasms
• Haemorrhage
• Tracheal Stenosis
• Non-small Cell Lung Cancer
  •  carcinoid
  •  cystic carcinoma
  •  mucoepidermoid carcinoma
  •  endobronchial metastases

By End User:

• Hospitals
• Speciality Care Centres
• Academic and Research Institutions

By Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa

 

Neurology digital therapeutics is the field of healthcare that deals with and prevents medical conditions using information and communication technology. According to the recent research by FMI, the neurology digital therapeutics market is anticipated to witness a 9.0% growth during the forecast period from 2021 to 2031. This significant growth will be experienced due to the advancement in technology in the healthcare sector. Therefore, neurology digital therapeutics demand is expected to increase significantly soon.

What is Driving Demand for Neurology Digital Therapeutics?

Various factors are driving the demand for neurology digital therapeutics such as it optimizes the time of administrative tasks and routine communication, it reduces the pain associated with the traditional therapeutic methods, it make the monitoring easier and more accurate.

These technologies can also be used for therapy and rehabilitation purposes with the help of smartphones, tablets and computers.

Also, neurological digital therapeutics can overcome various problems related to traditional clinical practices. Thus, all these factors have the potential to drive the demand of the market during the forecast period from 2021 to 2031.

Ask for brochure of Market @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-14231

Advancement in Information Technology Likely to Augment Neurology Digital Therapeutics

Information technology work in conjugation with the drugs to give maximum benefit of the treatment to the patients. Patients can take care of their health through easy-to-use apps and monitoring devices. Start-ups are introducing different innovative ideas to attract investors.

Also, the prevalence of chronic diseases is rising in the world that creating opportunities for healthcare and digital therapy players to invest in the market by innovating and launching technological advanced devices and enhance the neurological digital therapeutics demand globally.

The treatment of chronic diseases with the traditional method is becoming a challenging thing for healthcare workers and manufacturers due to its increasing burden. Thus, innovative technology or digital therapeutics is required for the treatment of a large number of populations suffering from chronic diseases.

Thus, it is expected to boost the market of neurology digital therapeutics during the forecast period from 2021 to 2031 in the world.

The U.S. and Canada Neurology Digital Therapeutics Market Outlook

U.S. and Canada remain the predominant market for neurology digital therapeutics because of the presence of key players in the region. For instance, Pear Therapeutics headquartered in the U.S. operates at the intersection of biology and software technology. The company discovers, develops, and delivers clinically certified software to provide better outcomes for patients using neurological digital therapeutics.

Thus, the demand for neurology digital therapeutics will increase in the region during the forecast period from 2021 to 2031.

Europe Demand Outlook for Neurology Digital Therapeutics

The demand for neurology digital therapeutics will be increased in Europe because of a rising number of chronic disease amongst patients with rising geriatric populations in the region.

With increasing age, the chances of developing chronic diseases also increase in the region.

According to EUROSTAT, in 2020, there were 20.6% of people in Europe were more than 65 years of age.

Thus, there will be growth in the neurology digital therapeutics market in the region during the forecast period from 2021 to 2031.

Who are the Key Manufacturers and Suppliers of Neurology Digital Therapeutics?

The key players of neurology digital therapeutics include

• Livongo Health
• Noom
• Omada Health
• Pear Therapeutics
• WellDoc
• Proteus Digital Health
• Propeller Health
• Akili Interactive Labs
• Mango Health
• Better Therapeutics
• Happify
• Kaia Health
• Click Therapeutics and others.

They follow certain strategies to survive in the market like a product launch, product approval, patent gaining, expansion, acquisition and merger. For instance, in October 2021, Pear Therapeutics announced about continuing the expansion of intellectual property portfolio for prescription digital therapeutics.

The Report Covers Exhaustive Analysis on:

• Neurology Digital Therapeutics market  Segments
• Neurology Digital Therapeutics market  Dynamics
• Neurology Digital Therapeutics Market Size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies involved
• Technology
• Value Chain

Regional Analysis Includes:

• North America (U.S., Canada)
• Latin America ( Brazil, Mexico, Argentina, Rest of Latin America)
• Europe (Germany, Italy, UK, Spain, France, Russia, Rest of Europe)
• South Asia (India, Indonesia, Malaysia, Thailand, Rest of South Asia)
• East Asia (Japan, South Korea, China)
• Oceania ( Australia, New Zealand)
• The Middle East and Africa (GCC, Turkey, South Africa, Rest Of MEA)

Report Highlights:

• Detailed overview of Neurology Digital Therapeutics market
• Changing market dynamics in the industry
• In-depth Neurology Digital Therapeutics market  segmentation
• Historical, current and projected market size in terms of volume and value.

Note: Although care has been taken to maintain the highest levels of accuracy in reports, recent market/vendor-specific changes may take time to reflect in the analysis.

For Complete TOC @ https://www.futuremarketinsights.com/toc/rep-gb-14231

Key Segments

By Product Type:

• Software
• Devices

By Indication:

• Diabetes
• Obesity
• Cardiovascular Disease (CVD)
• Central Nervous System (CNS) Disease
• Respiratory Disease
• Others

By End User:

• Hospital
• Clinics
• Others

By Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• MEA

 

According to the latest research by Future Market Insights, quadriplegia treatment market is expected to grow at a CAGR of 4.1% during the forecast period. The demand for quadriplegia treatment will progressively rise, which will provide manufacturers with numerous favorable development opportunities in the near future.

Quadriplegia is caused by spinal cord injury which is caused due to trauma at the base of the neck or skull. Some of the common causes of quadriplegia, otherwise known as tetraplegia are paralysis after any accident, tumors of the spinal cord or other spinal cord diseases. The injury to the spinal cord may cause partial or total limb paralysis.

According to 2020 data sheet of Spinal Cord Injury Statistics, it was estimated that approximately 17,810 new cases of spinal cord injuries occur every year in the U.S. Some of the reasons for quadriplegia include stroke, vehicular accidents, falls, violence, sports, medical or surgical causes and others.

Request for Report brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-14232

According to WHO statistics, published in June 2021, 20-50 million people suffer from road traffic accidents every year which lead to non-fatal injuries yet permanent disabilities to them. With the increasing rate of road traffic accidents, the demand for quadriplegia treatment is set to show a positive growth over the forecast period.

Recent technological advancements and various R&D activities in the field of quadriplegia treatment are one of the leading causes which will boost the demand for this market in forthcoming years. There is an increased level of awareness amongst the patients suffering from spinal cord injuries about various treatment options available to improve their quality of life. This is another factor which will propel the demand for various treatments for quadriplegia during the forecast market.

Electrical Stimulation: Revolutionary Technique that Got Quadriplegic People Back on their Feet.

Electrical stimulators which were originally designed to treat chronic pain helped more than a dozen patients with quadriplegia to wiggle their toes, flex their legs or even walk with support.

This was a revolutionary technique which was conducted in the lab of University of Louisville in Kentucky. Electrical stimulation thus made promising and huge gains for people with paralysis wanting to regain their functionalities. The study was published in July 2019, after which thousands of patients have enrolled in the wait lists for the electrical stimulation technique.

U.S. and Canada Quadriplegia Treatment: Regional Outlook

U.S. and Canada region was found to be the largest market for the diagnosis and treatment of spinal cord injury (SCI). Increasing awareness and advanced technologies are the main drivers of this market. Most of the accidents found that alcohol was one of the most important factors; that is, approximately 25% of spinal cord injuries.

In the United States, the average annual medical cost for treating an acute spinal cord injury has been found to be in the range of $ 15,000 to $ 30,000 per year. All these factors are expected to drive the market growth of quadriplegia treatment market and offer lucrative opportunities for the providers.

Europe Quadriplegia Treatment: Regional Outlook

Europe was observed to be the second largest market, region wise for the quadriplegia treatment industry. Some of the factors contributing to this large market share are the presence of leading research institutes in the region for various neurological disease diagnosis and treatment. Increased awareness regarding various new technologies which help the quadriplegic patients lead a relatively normal life is also another key driver for this industry in Europe.

Who are the key player of Quadriplegia Treatment Market?

Major manufacturers of medications needed to treat quadriplegia are

• Merck & Co.
• Sanofi Pharmaceuticals
• Baxter International
• Zydus Cadila
• GlaxoSmithKline
• AstraZeneca
• Cipla
• Johnson & Johnson
• Bristol Myers Squibb Co.
• Eli Lily & Co.
• Teva Pharmaceuticals
• Takeda Pharmaceutical Co Ltd
• Hoffmann La Roche
• Sun Pharmaceuticals.

In November 2020, Pfizer and Mylan announced the merger of Pfizer’s Upjohn generics unit and Mylan. This deal was a part of restructuring drive at Pfizer, which was aimed for stronger foothold in the innovative medicines division of the company.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Quadriplegia Treatment Market Report Highlights:

• Shifting Industry dynamics.
• In-depth market segmentation.
• Historical, current and projected industry size recent industry trends.
• Key Competition landscape.
• Strategies for key players and product offerings.
• Potential and niche segments/regions exhibiting promising growth.
• A neutral perspective towards market performance.

Note: Although care has been taken to maintain the highest levels of accuracy in reports, recent market/vendor-specific changes may take time to reflect in the analysis.

For Complete TOC @ https://www.futuremarketinsights.com/toc/rep-gb-14232

Key Segments

By Treatment Type:

• Corticosteroids
• Non- Steroidal Anti-inflammatory Drugs (NSAIDs)
• Antidepressants
  • Selective serotonin reuptake inhibitors (SSRIs)
  • Serotonin and norepinephrine reuptake inhibitors (SNRIs)
• Anticonvulsants
• Narcotic Analgesics
• Antispasmodics & Muscle Relaxants
• Antibiotics

By Route of Administration:

• Oral
• Intravenous
• Others

By Distribution Channel:

• Hospital Pharmacies
• Retail Pharmacies
• Drug Stores
• Online Stores?

By Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• MEA

FMI, an ESOMAR-certified market research firm, states that the global hospital capacity management solutions market will reach US$ 994 Mn in 2020, growing at 5% y-o-y in 2020.

Investment in RTLS (Real Time Location System) is growing among end-users. According to FMI’s estimate, nearly 30% of all spending on hospital capacity management solutions market can be attributed to real time location systems.

Regulatory enforcement of RTLS across the entire healthcare vertical is driving this market share. Another factor fueling the market includes an increasing use of RTLS system-based crisis response & emergency management in healthcare. Through this feature, patients’ assets can be easily tracked.

The approximately US$ 25 Bn market for benign prostatic hyperplasia prostate treatment is likely to expand at 4.6% CAGR during 2018-2028, according to a recent research report of Future Market Insights (FMI). The report has envisaged steady growth prospects for the revenue of global benign prostatic hyperplasia prostate treatment market through 2028.